drug,class,target,bacterium,gram,strain,mutation,technique,MIC,medium,selcoef,fitness
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoB V1080I,1,20,MH,-0.115415603,0.864
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoB V1080L,1,20,MH,-0.173123405,0.796
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoB E1084K,1,100,MH,-0.115415603,0.864
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoB D1101E,1,20,MH,-0.216404256,0.745
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoB S1127L,1,100,MH,-0.144269504,0.83
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoB S1127P,1,100,MH,-0.057707802,0.932
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoC K334N,1,100,MH,-0.086561702,0.898
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoC T925K,1,20,MH,-0.100988653,0.881
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoC T925R,1,100,MH,-0.072134752,0.915
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoC G1172C,1,20,MH,-0.187550355,0.779
myxopyronin,alpha-pyrone,"rpoB, rpoC",S. aureus,positive,ATCC 12600,rpoC G1172D,1,20,MH,-0.201977306,0.762
streptomycin,aminoglycoside,16sRNA,M. smegmatis,positive,SMR5,16S rRNA C522T,1,250,BHI medium,-0.134891986,0.84105
streptomycin,aminoglycoside,16sRNA,M. smegmatis,positive,SMR5,16S rRNA A523C,1,125,BHI medium,-0.088725745,0.89545
streptomycin,aminoglycoside,16sRNA,M. smegmatis,positive,SMR5,16S rRNA G524C,1,500,BHI medium,-0.566257804,0.33275
streptomycin,aminoglycoside,16sRNA,M. smegmatis,positive,SMR5,16S rRNA C526T ,1,125,BHI medium,-0.201255958,0.76285
amikacin,aminoglycoside,30SrRNA,M. smegmatis,positive,SMR5,16S rRNA A1408G,1,833.333,BHI medium,-0.023804468,0.97195
streptomycin,aminoglycoside,16sRNA,M. smegmatis,positive,SMR6,16S rRNA A523C,5,125,BHI medium,-0.07862688,0.90735
streptomycin,aminoglycoside,16sRNA,M. smegmatis,positive,SMR7,16S rRNA G524C,5,500,BHI medium,-0.600161137,0.2928
streptomycin,aminoglycoside,16sRNA,M. smegmatis,positive,SMR8,16S rRNA C526T,5,125,BHI medium,-0.113972908,0.8657
amikacin,aminoglycoside,30SrRNA,M. smegmatis,positive,SMR9,16S rRNA A1408G,5,833.333,BHI medium,-0.042559504,0.94985
novobiocin,coumarin,type II topoisomerase enzymes (DNA gyrase and topo IV),S. aureus,positive,SH1000,gryB G85S,1,62.5,ISB,-0.04,0.96
novobiocin,coumarin,type II topoisomerase enzymes (DNA gyrase and topo IV),S. aureus,positive,SH1000,gyrB R144S,1,62.5,ISB,-0.05,0.95
coumermycin,coumarin,type II topoisomerase enzymes (DNA gyrase and topo IV),S. aureus,positive,SH1000,gyrB T173I,1,62.5,ISB,-0.04,0.96
trimethoprim,dihydrofolate reductase inhibitor,Dihydrofolate reductase (DHFR),S. aureus,positive,SH1000,DHFR L41F,1,4,ISB,0.028853901,1.034
trimethoprim,dihydrofolate reductase inhibitor,Dihydrofolate reductase (DHFR),S. aureus,positive,SH1000,DHFR F99S,1,4,ISB,0.043280851,1.051
trimethoprim,dihydrofolate reductase inhibitor,Dihydrofolate reductase (DHFR),S. aureus,positive,SH1000,DHFR H150R,1,8,ISB,-0.01442695,0.983
trimethoprim,dihydrofolate reductase inhibitor,Dihydrofolate reductase (DHFR),S. aureus,positive,SH1000,DHFR F99Y,1,16,ISB,0.01442695,1.017
fusidic acid,fusidane,"EF-G, ribosome",S. aureus,positive,RN4220,EF-G A67T,4,1,yeast extract peptone,-0.031739651,0.962599576
fusidic acid,fusidane,"EF-G, ribosome",S. aureus,positive,RN4220,EF-G P406L,4,250,yeast extract peptone,-0.443538564,0.477356241
fusidic acid,fusidane,"EF-G, ribosome",S. aureus,positive,RN4220,EF-G S416F,4,1,yeast extract peptone,-0.047361381,0.944191707
fusidic acid,fusidane,"EF-G, ribosome",S. aureus,positive,RN4220,EF-G H457Y,4,2000,yeast extract peptone,-0.308353681,0.636651376
clarithromycin,macrolide,23S rRNA,M. smegmatis,positive,SMR5,23S rRNA A2058G,1,2133.3333,BHI medium,-0.028853901,0.966
clarithromycin,macrolide,23S rRNA,M. smegmatis,positive,SMR5,23S rRNA A2059G,1,2133.3333,BHI medium,-0.028132553,0.96685
erythromycin,macrolide,23S rRNA,C. jejuni,negative,NCTC 11168,23S A2074C,1,512,MH,-0.17,0.83
erythromycin,macrolide,23S rRNA,C. jejuni,negative,81-176,23S A2075G,2,256,MH,-0.18,0.82
erythromycin,macrolide,23S rRNA,C. jejuni,negative,81-176,23S A2075G,2,256,MH,-0.2,0.8
erythromycin,macrolide,23S rRNA,C. jejuni,negative,81-176,23S A2075G,2,256,MH,-0.16,0.84
erythromycin,macrolide,23S rRNA,C. jejuni,negative,81-176,23S A2075G,2,256,MH,-0.155,0.845
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),S. aureus,positive,SH1000,grlA S80F,1,8,ISB,-0.02,0.98
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),S. aureus,positive,SH1000,grlA S80Y,1,8,ISB,-0.04,0.96
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),S. aureus,positive,SH1000,grlA E84K,1,8,ISB,0.02,1.02
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),S. aureus,positive,SH1000,grlA A116E,1,8,ISB,0.02,1.02
ciprofloxacin,quinolone,quinolone-resistance determining region (QRDR) topoIV genes and DNA gyr,S. pneumoniae,positive,R6,parC S79F,2,2,Todd-Hewitt yeast broth,-0.083,0.917
ciprofloxacin,quinolone,quinolone-resistance determining region (QRDR) topoIV genes and DNA gyr,S. pneumoniae,positive,R6,parC S79Y,2,2,Todd-Hewitt yeast broth,0.004,1.004
ciprofloxacin,quinolone,quinolone-resistance determining region (QRDR) topoIV genes and DNA gyr,S. pneumoniae,positive,R6,parC D83Y,2,3,Todd-Hewitt yeast broth,0.07,1.07
ciprofloxacin,quinolone,quinolone-resistance determining region (QRDR) topoIV genes and DNA gyr,S. pneumoniae,positive,R6,parE D435N,2,2,Todd-Hewitt yeast broth,-0.439,0.561
ciprofloxacin,quinolone,quinolone-resistance determining region (QRDR) topoIV genes and DNA gyr,S. pneumoniae,positive,R6,gyrA S81Y,2,2,Todd-Hewitt yeast broth,0.01,1.01
ciprofloxacin,quinolone,quinolone-resistance determining region (QRDR) topoIV genes and DNA gyr,S. pneumoniae,positive,R6,gyrA E85K,2,1,Todd-Hewitt yeast broth,-0.076,0.924
ciprofloxacin,quinolone,quinolone-resistance determining region (QRDR) topoIV genes and DNA gyr,S. pneumoniae,positive,R6,gyrA S81F,2,1,Todd-Hewitt yeast broth,-0.099,0.901
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu14,gyrA S83A,1,2.659574468,urine,0.001442695,1.0017
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu14,gyrA D87Y,1,5.319148936,urine,-0.007213475,0.9915
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu15,gyrA D87G,1,10.63829787,urine,-0.001442695,0.9983
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu18,gyrB S464F,1,5.319148936,urine,0.033181986,1.0391
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu20,gyrB delta9nt,1,2.659574468,urine,0.012984255,1.0153
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu22,marR R77L,1,5.319148936,urine,-0.018755036,0.9779
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu14,marR R94H,1,4.042553191,urine,-0.004328085,0.9949
norfloxacin,quinolone,type II topoisomerase enzymes (DNA gyrase and topo IV),E. coli,negative,UTI isolate Nu14,marR delta13 nt,1,2.021276596,urine,0.004328085,1.0051
ciprofloxacin,quinolone,"topoIV, DNA gyr",E. coli,negative,MG1655,gyrA S83L,1,23.75,LB,0.01,1.01
ciprofloxacin,quinolone,"topoIV, DNA gyr",E. coli,negative,MG1655,gyrA D87N,1,15.625,LB,-0.01,0.99
ciprofloxacin,quinolone,"topoIV, DNA gyr",E. coli,negative,MG1655,parC S80I,1,1,LB,-0.01,0.99
ciprofloxacin,quinolone,"topoIV, DNA gyr",E. coli,negative,MG1655,marR delta,1,2,LB,-0.17,0.83
ciprofloxacin,quinolone,"topoIV, DNA gyr",E. coli,negative,MG1655,acrR delta,1,2.9375,LB,-0.09,0.91
ciprofloxacin,quinolone,"topoIV, DNA gyr",S. pneumoniae,positive,clinical strain,parC S79Y,1,8,heart infusion broth,-0.15,1.15
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,REL1206,rpoB I572F,4,320,DM25,0.35490298,1.4182
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,REL1206,rpoB I572L,4,40,DM25,0.304408654,1.3587
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,REL1206,rpoB 1572N,4,10,DM25,0.262570497,1.3094
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,REL606,rpoB I572F,4,320,DM25,0.409725392,1.4828
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,REL606,rpoB I572L,4,40,DM25,0.435693902,1.5134
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,REL606,rpoB 1572N,4,10,DM25,0.428480427,1.5049
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12,rpoB I572F,4,320,DM25,-0.132150866,0.84428
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12,rpoB I572L,4,40,DM25,-0.038952766,0.9541
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"4 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB H489Q,1,32,modified peptone water,-0.016,0.984
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"4 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB H489Y,1,64,modified peptone water,0.22,1.22
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"4 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB R492H,1,256,modified peptone water,-0.095,0.905
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"5 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB H489Y,1,64,modified peptone water,-0.027,0.973
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"6 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB R492H,1,256,modified peptone water,-0.095,0.905
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"7 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB H489Y,1,96,modified peptone water,-0.042,0.958
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"8 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB H489Y,1,32,modified peptone water,-0.026,0.974
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"9 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB H489Y,1,32,modified peptone water,-0.032,0.968
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. faecium,positive,"4 independent isolates pig intestine (38-15, 40-4, 40-8, 343-3)",rpoB Q480H,1,64,modified peptone water,-0.029,0.971
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),M. tuberculosis,positive,Harlingen,rpoB S531W ,1,128,7H9 medium,-0.29,0.71
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),M. tuberculosis,positive,Harlingen,rpoB H526Y,1,128,7H9 medium,-0.14,0.86
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),M. tuberculosis,positive,Harlingen,rpoB S522L,1,64,7H9 medium,-0.05,0.95
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB I572L,1,16,Davis minimal media,-0.136,0.864
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB L511Q,1,4,Davis minimal media,-0.135,0.865
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB H526L,1,16,Davis minimal media,-0.056,0.944
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1656,NA,1,16,Davis minimal media,0.046,1.046
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB Q148L,1,32,Davis minimal media,-0.037,0.963
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB H526Y,1,32,Davis minimal media,-0.087,0.913
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB Q418L,1,8,Davis minimal media,-0.104,0.896
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB P564L,1,320,Davis minimal media,-0.165,0.835
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),E. coli,negative,K12 MG1655,rpoB D516G,1,16,Davis minimal media,0.03,1.03
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB H481N,3,500,LB,0,1
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB N471Y,3,500,LB,-0.12,0.88
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB N471Q,3,62.5,LB,-0.04,0.96
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB N471G,3,62.5,LB,-0.13,0.87
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB I527F,3,500,LB,-0.07,0.93
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB S464P,3,500,LB,-0.07,0.93
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB N474K,3,1000,LB,-0.4,0.6
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB A477V,3,125,LB,-0.12,0.88
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB A477N,3,32000,LB,-0.09,0.91
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB R484H,3,32000,LB,-0.25,0.75
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB S486L,3,64000,LB,-0.14,0.86
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB Q468R,3,64000,LB,-0.2,0.8
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB Q468L,3,64000,LB,-0.05,0.95
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,various clinical isolates,rpoB H481Y,3,64000,LB,-0.07,0.93
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB D471E,4,15.625,LB,-0.086561702,0.898
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB Q137L,4,15.625,LB,-0.187550355,0.779
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB Q137L,4,31.25,LB,-0.216404256,0.745
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB L466S,4,31.25,LB,-0.057707802,0.932
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB D471E,4,31.25,LB,-0.302965959,0.643
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB Q137L,4,31.25,LB,-0.245258157,0.711
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB H481N,4,250,LB,-0.288539008,0.66
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB A477V,4,250,LB,-0.605931917,0.286
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB A477V,4,250,LB,-0.605931917,0.286
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB deltaL485,4,500,LB,-0.274112058,0.677
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB D471Y,4,500,LB,-0.230831207,0.728
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB D471Y,4,1000,LB,-0.375100711,0.558
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB I527F,4,2000,LB,-0.01442695,0.983
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB S464P,4,2000,LB,-0.418381562,0.507
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB L488S,4,16000,LB,-0.01442695,0.983
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB P519L,4,32000,LB,-0.317392909,0.626
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB A477D,4,64000,LB,-0.562651066,0.337
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB S486L,4,128000,LB,-0.519370215,0.388
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB S486L,4,128000,LB,-0.36067376,0.575
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB H481D,4,128000,LB,-0.591504967,0.303
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB H481Y,4,128000,LB,-0.72134752,0.15
rifampicin,rifamycin,rpoB (beta-subunit of RNA pol),S. aureus,positive,8325-4,rpoB H481Y,4,128000,LB,-0.735774471,0.133